TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Boule Diagnostics AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
558,463
|
571,329
|
548,087 |
| Financial expenses |
12,592
|
11,336
|
9,904 |
| Earnings before taxes |
-360,751
|
30,100
|
20,849 |
| EBITDA |
-325,208
|
65,836
|
56,178 |
| Total assets |
516,907
|
755,105
|
759,964 |
| Current assets |
254,783
|
279,931
|
338,414 |
| Current liabilities |
261,297
|
202,999
|
199,534 |
| Equity capital |
196,367
|
475,096
|
462,504 |
| - share capital |
9,708
|
9,708
|
9,708 |
| Employees (average) |
226
|
228
|
235 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
38.0%
|
62.9%
|
60.9% |
| Turnover per employee |
2,471
|
2,506
|
2,332 |
| Profit as a percentage of turnover |
-64.6%
|
5.3%
|
3.8% |
| Return on assets (ROA) |
-67.4%
|
5.5%
|
4.0% |
| Current ratio |
97.5%
|
137.9%
|
169.6% |
| Return on equity (ROE) |
-183.7%
|
6.3%
|
4.5% |
| Change turnover |
-12,866
|
23,242
|
84,743 |
| Change turnover % |
-2%
|
4%
|
18% |
| Chg. No. of employees |
-2
|
-7
|
17 |
| Chg. No. of employees % |
-1%
|
-3%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.